Radiaction Opens First EU Radiation Protection Center of Excel... - 23 February 2022 12:00

TEL AVIV, Israel, Feb. 23, 2022 /PRNewswire-AsiaNet/ -- Radiaction Medical Ltd. [https://www.radiactionmedical.com/] ("Radiaction"), an innovative medical device company focused on radiation protection in the interventional cardiology and electrophysiology sectors, has entered into a new collaboration ...

  Hovione and Zerion Pharma announce a strategic partnership to ... - 23 February 2022 04:46

LISBON, Portugal Feb. 22, 2022 /PRNewswire-AsiaNet/ -- Hovione, the leader in spray drying and particle engineering, announced today a strategic partnership with Zerion Pharma to market and commercialize Dispersome(R), Zerion´s proprietary solubility enhancement technology platform. Zerion´s innov...

  Nippon Express Obtains GDP Certification for Temperature-contr... - 22 February 2022 18:00

TOKYO, Feb. 22, 2022 /Kyodo JBN-AsiaNet/ -- - Providing High-quality Pharmaceutical Logistics Services with Strict Temperature and Quality Control - Nippon Express Co., Ltd. (hereinafter "Nippon Express"), a group company of Nippon Express Holdings, Inc., has obtained Good Distribution P...

  NIBIOHN, Shionogi Discover Host Immune-dependent Novel Anti-co... - 16 February 2022 17:00

OSAKA, Japan, Feb. 16, 2022 /Kyodo JBN-AsiaNet/ -- - Potential Candidate as Broad-spectrum Therapeutic Agent for Coronavirus Diseases Caused by Different Coronaviruses, including Variants - The National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN; Ibaraki-shi, Osaka; Dire...

  HPG: New Breakthrough in Virus Inactivation with Green Tea Cat... - 15 February 2022 19:00

TOKYO, Feb. 15, 2022 /Kyodo JBN-AsiaNet/ -- HPG Co., Ltd. (Chuo-ku, Tokyo) has successfully developed a water-soluble formulation technology of highly concentrated catechin EGCg (Epigallocatechin gallate) with excellent storage stability and initiated procedures for a patent application for...

  Clinical trials in Russia and Azerbaijan demonstrated safety o... - 14 February 2022 19:00

MOSCOW, Feb. 14, 2022 /PRNewswire-AsiaNet/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), R-Pharm group and AstraZeneca announce interim results of phase II clinical trials to evaluate the safety and immunogenicity of the combined use of AstraZeneca's vaccine an...

  Zimmer Biomet Opens ZBEdge Customer Experience Centre in Singa... - 11 February 2022 11:00

SINGAPORE, Feb. 11, 2022 /PRNewswire-AsiaNet/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today celebrated the opening of the ZBEdge Customer Experience Centre (CEC), a unique facility located at the company's Asia Pacific regional headquarters in Sin...

  Novavax Announces Positive Results of COVID-19 Vaccine in Pedi... - 11 February 2022 08:59

GAITHERSBURG, Md., Feb. 11, 2022 /PRNewswire-AsiaNet/ -- - PREVENT-19 pediatric expansion in adolescents aged 12 through 17 achieved primary effectiveness endpoint demonstrating comparability to adult population - Trial demonstrated 82% clinical efficacy against Delta variant - Immune responses we...

  GLOBAL HEALTH TECHNOLOGY PLATFORM, PROXIMIE, ANNOUNCES NEW SEN... - 10 February 2022 23:00

BOSTON, Feb. 10, 2022 /PRNewswire-AsiaNet/ -- - General Manager for the Americas - Charles H. Wilhelm, and Chief Growth Officer - Dave Herrmann, appointed Proximie, the global health technology platform digitizing operating rooms (OR) around the world, announces the appointments of a Gener...

  GenScript Sets Up State-Of-Art Manufacturing Facility in Singa... - 10 February 2022 21:38

SINGAPORE, Feb. 10, 2022 /PRNewswire-AsiaNet/ -- GenScript Biotech Corporation (Stock Code: 1548.HK), the world's leading life science research tools and services provider, today announced the opening of more than 30,000-square-feet facility for highly automated protein and gene preparation serv...